Genalyte to Collaborate with Davis Center on Diabetes Panel | GenomeWeb

NEW YORK (GenomeWeb News) – Genalyte today said that it has inked an agreement with the Barbara Davis Center for Childhood Diabetes at the University of Colorado School of Medicine to collaborate on the further development of multiplexed antigen panels for the early detection of T1D.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.